Pages that link to "Q43887478"

The following pages link to Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells (Q43887478):

Displaying 35 items.

• Molecular imaging in stem cell therapy for spinal cord injury (Q27023747) (← links)
• Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy (Q34158605) (← links)
• Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy (Q34480369) (← links)
• Repair of injured spinal cord using biomaterial scaffolds and stem cells (Q34803857) (← links)
• Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury (Q37635476) (← links)
• Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression. (Q37644379) (← links)
• Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application (Q38162491) (← links)
• The known-unknowns in spinal cord injury, with emphasis on cell-based therapies - a review with suggestive arenas for research (Q38198731) (← links)
• Current status of cell-mediated regenerative therapies for human spinal cord injury (Q38210966) (← links)
• Mesenchymal stem cells as a potential therapeutic tool for spinocerebellar ataxia. (Q38256491) (← links)
• The Evaluation of Nerve Growth Factor Over Expression on Neural Lineage Specific Genes in Human Mesenchymal Stem Cells (Q38751098) (← links)
• Clinical Study of NeuroRegen Scaffold Combined With Human Mesenchymal Stem Cells for the Repair of Chronic Complete Spinal Cord Injury (Q38759038) (← links)
• Mesenchymal stem cells ameliorate cerebellar pathology in a mouse model of spinocerebellar ataxia type 1. (Q39313433) (← links)
• A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries (Q40185911) (← links)
• A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients (Q40185923) (← links)
• Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC). (Q42019222) (← links)
• Spinal Cord Molecular and Cellular Changes Induced by Adenoviral Vector- and Cell-Mediated Triple Gene Therapy after Severe Contusion. (Q45875097) (← links)
• Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis (Q46404769) (← links)
• PSA-NCAM( ) neural precursor cells from human embryonic stem cells promote neural tissue integrity and behavioral performance in a rat stroke model. (Q48690209) (← links)
• Phase I-II Clinical Trial Assessing Safety and Efficacy of Umbilical Cord Blood Mononuclear Cell Transplant Therapy of Chronic Complete Spinal Cord Injury. (Q52140295) (← links)
• Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). (Q52863563) (← links)
• Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. (Q53240200) (← links)
• Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury. (Q53570871) (← links)
• Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses. (Q55091426) (← links)
• Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study (Q58749229) (← links)
• The Science and Clinical Applications of Placental Tissues in Spine Surgery (Q64333996) (← links)
• Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial (Q88801579) (← links)
• Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin (Q90258158) (← links)
• A scoping review of trials for cell-based therapies in human spinal cord injury (Q91583982) (← links)
• Efficient One-Step Induction of Human Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) Produces MSC-Derived Neurospheres (MSC-NS) with Unique Transcriptional Profile and Enhanced Neurogenic and Angiogenic Secretomes (Q92616598) (← links)
• Nanomaterial-Based Approaches for Neural Regeneration (Q92636315) (← links)
• Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases (Q92712916) (← links)
• Human umbilical cord mesenchymal stem cells to treat spinal cord injury in the early chronic phase: study protocol for a prospective, multicenter, randomized, placebo-controlled, single-blinded clinical trial (Q93047829) (← links)
• Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study (Q97686593) (← links)
• A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patients (Q99729467) (← links)